| Names | |
|---|---|
| Preferred IUPAC name | 1-(3-chlorophenyl)-3-methyl-1,2-dihydro-5H-pyrazol-5-one |
| Other names | 4-Aminoantipyrine impurity E 1-(3-chlorophenyl)-3-methyl-1H-pyrazol-5(4H)-one |
| Pronunciation | /wʌn θri ˈklɔːrəʊˈfiːnɪl θri ˈmɛθɪl faɪ ˈpaɪrəˌzoʊn/ |
| Identifiers | |
| CAS Number | 89-25-8 |
| Beilstein Reference | 107812 |
| ChEBI | CHEBI:139488 |
| ChEMBL | CHEMBL258180 |
| ChemSpider | 21599670 |
| DrugBank | DB03725 |
| ECHA InfoCard | 03f1107c-db34-498d-ba83-ecb4785905e4 |
| EC Number | EC 607-517-7 |
| Gmelin Reference | Gm 18 450 |
| KEGG | C14385 |
| MeSH | D017382 |
| PubChem CID | 71280091 |
| RTECS number | XZ1875000 |
| UNII | 08L7CQJ16I |
| UN number | 2811 |
| Properties | |
| Chemical formula | C10H9ClN2O |
| Molar mass | 221.65 g/mol |
| Appearance | white solid |
| Odor | Odorless |
| Density | 1.32 g/cm³ |
| Solubility in water | slightly soluble |
| log P | 2.3 |
| Vapor pressure | 1.06E-04 mmHg at 25°C |
| Acidity (pKa) | 7.52 |
| Basicity (pKb) | 7.98 |
| Magnetic susceptibility (χ) | -54.72×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.6000 |
| Dipole moment | 3.73 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 326.7 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -44.37 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3902.6 kJ/mol |
| Pharmacology | |
| ATC code | N02BB02 |
| Hazards | |
| Main hazards | H302, H315, H319, H335 |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P261, P264, P271, P272, P273, P280, P302+P352, P305+P351+P338, P312, P321, P332+P313, P362+P364, P337+P313, P501 |
| Flash point | 112.9°C |
| Lethal dose or concentration | > LD50 oral rat 3900 mg/kg |
| LD50 (median dose) | LD50 (median dose): 3400 mg/kg (oral, rat) |
| NIOSH | NA2238000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.05 mg/m³ |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds | Antipyrine 4-Aminoantipyrine Dipyrone Phenazone Edaravone |
| Category | Details | Manufacturer Commentary |
|---|---|---|
| Product Name & IUPAC Name | 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone IUPAC: 1-(3-chlorophenyl)-3-methyl-1,5-dihydro-2H-pyrazol-5-one |
In plant operation, this compound appears as a crystalline or powdery solid, with the product form and particle size reflecting how the crystallization and drying steps are managed. Technical documentation tracks precise raw material charge ratios to ensure the right substitution pattern on the pyrazolone ring, especially for pharmaceutical or pigment applications where positional isomer purity is critical. |
| Chemical Formula | C10H9ClN2O |
This molecular formula matches a target monomer unit formed from chlorinated aniline and methylpyruvic acid derivatives. Process yield and byproduct profile vary if upstream aromatics contain ortho, meta, or para-substituted chlorines—batch records note these distinctions. |
| Synonyms & Trade Names | 3'-Chloro-1-phenyl-3-methyl-5-pyrazolone, 3-Methyl-1-(3-chlorophenyl)-5-pyrazolone, CCPP |
Different grades and end-use industries—dyes, intermediates, analytical reagents—favor alternate synonyms. Specification sheets clarify if these refer to the same product or minor technical variants, as impurities from ring substitution or halogen migration vary with process setup. |
| HS Code & Customs Classification | 2933.19 (Heterocyclic compounds with nitrogen hetero-atom(s) only) |
Experienced regulatory teams verify that the HS Code selection reflects the functionalized pyrazolone core, not broader heterocyclic or generic organic intermediates. Trade compliance checks regularly address misclassification risk, as penalties and shipment delays arise if a product crosses customs with mismatched documentation or declared technical function. |
In production environments, 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone typically appears as a crystalline solid. Color may range from off-white to pale yellow, influenced by both batch purity and synthesis route. Odor is not noticeable under ordinary conditions, aligning with most aromatic pyrazolones in this class.
Melting point shows dependency on grade and residual solvent content; finer purification steps sharpen the melting range. Boiling point can only be discussed for decomposed or sublimate fractions, as aromatic substituted pyrazolones tend to decompose before boiling at atmospheric pressure.
Density varies with residual moisture and inclusions of crystalline solvents, when present, and firms generally track this parameter for process validation instead of tight release specifications.
The molecular structure offers notable thermal stability, but exposure to strong acids or bases triggers degradation or ring cleavage. We have tracked batch stability under simulated transportation, and found sensitivity to strong oxidizing agents and compounds capable of electrophilic substitution, which becomes particularly relevant for any site looking to make derivatives or run downstream reactions.
Solubility depends on both the medium and the product grade. Most industrial samples show moderate solubility in polar organic solvents, with significant grade-to-grade variation caused by trace impurities or coprocessed excipients. Water solubility remains low, so formulators working in aqueous media must use suspension or dispersion aids.
During formulation, the choice of solvent for solution preparation can impact impurity carryover; hence, solvent compatibility screening forms part of product application support for each customer.
Numerical values for assay, loss on drying, and key impurity limits are tailored to the intended sector (such as fine chemicals or research grade), and based on end-user processes. Detailed specifications are available on request and are always correlated to production records from the validated route.
Impurity content tracks chiefly with route selection and purification control. Major impurities typically originate from unreacted starting materials and side products from pyrazolone ring closure. For advanced grades, we target minimization using controlled recrystallization and tailored filtration. Monitor traces of halogenated benzene derivatives and pyrazolone ring isomers per internal limits agreed upon with downstream processors.
Assay testing refers to HPLC or titrimetric methods qualified for the specific grade. Impurity quantification leverages calibrated reference standards, and results are verified by batch retain sampling. Companies often update analytical SOPs as new customer requirements emerge, always reflecting the most robust compendial or in-house developed procedures.
Selection of chloro-substituted benzene and methylhydrazine or similar pyrazolone ring precursors depends on supply reliability and impurity carryover profile. Source verification and traceability audits ensure consistent batch-to-batch quality.
Industrial production follows a multi-step condensation and cyclization process. Route optimization considers reagent stoichiometry, reaction time, and minimization of hazardous byproducts. Process adaptation may be needed if customer application needs shift, especially for downstream pharmaceutical use.
Critical control points include reaction temperature management and containment of volatiles. Filtration and recrystallization steps are tailored to each product grade, using solvent systems selected for both yield and impurity rejection. Dedicated process lines protect against cross-contamination with other substituted pyrazolones.
Release testing encompasses assay, impurity content, and residual solvent profile. Adjust the test panel as per customer application—more rigorous for pharmaceutical intermediates, adapted for industrial or technical applications. The final batch is approved only after review of production, analytical, and quality records.
1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone supports electrophilic aromatic substitution, nucleophilic substitution at the 3-chloro position, and condensation with carbonyl or amine functionalities. Such reactivity forms the core of its use as a building block in downstream synthesis.
Aromatic substitutions and modifications usually proceed in polar aprotic solvents under controlled temperature. Reaction optimization considers not only yield but also downstream contamination potential—residual halide byproducts are a recurring concern flagged during scale-up.
The compound allows for preparation of various azo dyes, pharmaceutical intermediates, and specialty chemicals. Product tailoring for each application includes both impurity controls and process compatibility checks.
Material integrity benefits from dry, ambient storage out of direct sunlight. Temperature excursions above recommended ranges can promote color change or decomposition, especially for unformulated bulk stock. High humidity affects hygroscopicity depending on the grade.
Drums and containers made from high-density polyethylene or lined steel resist attack by chlorinated aromatic compounds and avert batch contamination during long-term storage. Container selection aligns with logistical chain and regulatory requirements for each shipment region.
Shelf life projections use historical retention sample data together with stress testing results. Visible degradation may include discoloration, clumping, or generation of unusual odors; each signal should prompt retesting prior to use.
Internal risk assessments follow chemical safety classification principles. The substance typically receives precautionary labeling regarding eye and skin irritation based on structure-activity relationship and supporting experimental data. Always check regulatory status for the specific market.
Use of personal protective equipment mitigates exposure risk during bulk handling. Operators follow established procedures for chemical containment, clean-up, and disposal, established through regular safety audits.
Acute and chronic toxicity profiles are established through literature review and acute toxicity screens; customer access to available data is provided on request for regulatory or risk assessment purposes.
Field-established exposure controls center around dust suppression, ventilation, and local exhaust installation. These measures hold particular relevance in spray-drying, packaging, and formulation stages, where airborne solids and vapors may present a workplace hazard.
Our integrated manufacturing sites maintain production lines dedicated to phenylpyrazolone derivatives, with the ability to adjust batch size based on downstream contract volume, plant turnaround schedules, and raw material lead times. Output capacity depends on the specific grade, as pharmaceutical and agrochemical intermediate grades often require additional purification or process steps, lowering throughput compared to technical grade. Historical observations show that campaign-based production planning, seasonality of upstream intermediates, and regulatory audits affect slotting and output scheduling. Temporary supply constraints may occur during feedstock interruptions, major equipment maintenance, or quality-driven batch reprocessing.
Standard lead time in regular campaign production falls in the 3–5 week range, but expedited schedules can be managed for repeat orders or inventory-backed grades. Custom synthesis or specification-tightened lots require added development or scale-up time. Minimum order quantity is typically negotiated based on both grade and downstream process requirements, with higher MOQs on small-volume, high-purity applications due to campaign and changeover costs. For R&D grade or pre-commercial evaluations, pilot-scale batch lots can be supplied, with release criteria reflecting lab-scale reproducibility protocols.
As the product is sensitive to moisture and requires controlled handling, packaging is available in internally lined drums, HDPE bottles, or composite containers, scaled according to lot size and customer handling infrastructure. Regulatory and compliance-driven customers (pharma, regulated agro) often require documented packaging integrity testing and lot traceability. Packaging material compatibility and cleaning protocols follow batch-to-batch cross-contamination prevention SOPs.
We facilitate both EXW and CIF shipping terms, depending on customer region, carrier certification requirements, and downstream transportation methods. For sensitive grades, lane qualification and logistics audits are part of regular supplier evaluation. Payment terms are established by long-term business relationship, credit assessment, and region, with advance payment commonly required for small-scale or first-time purchases and net-terms negotiable for repeated or contract-based supply chains.
Cost structure analysis for 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone places chlorinated aromatic intermediates, pyrazolone-forming reagents, and solvents at the heart of price formation. Major volatility inputs relate to crude oil price-driven changes in aromatic feedstocks and the seasonal operating rates of regional chlorination plants. The use of high-purity or compliance-certified starting materials, common in pharma-intermediate grades, significantly increases procurement costs.
Raw material prices shift due to a combination of supply chain bottlenecks (plant shutdowns, transportation disruptions in major chemical regions like Jiangsu or Gujarat), environmental regulation enforcement (especially in China and India regarding waste discharge and process emissions), and global demand spikes linked to downstream active ingredients. Trade policy changes or local safety crackdowns on hazardous substances directly affect chlorination routes and available supply.
Price brackets are strictly grade-dependent. Technical grades, with standard process purity and packaging, command the lowest premiums, while pharmaceutical or electronics grades, subject to additional QA/QC release tests (HPLC purity, residual solvent, trace metal content), attract substantial markups. For each customer or application, price is also impacted by packaging form certification, documentation needs, and the thoroughness of batch release support. Shipment scale, route choice, and international compliance further influence the quoted price spread.
Demand for 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone reflects regional patterns in pharmaceutical and agrochemical intermediate consumption. China and India drive a majority of global output and export volumes, leveraging mature synthetic capacity, competitive labor costs, and relaxed process regulation for several grades. In the US and EU, supply chain risk management and qualification hurdles for secondary sourcing increase local pricing, while domestic manufacturing mainly targets high-value or niche variants.
US buyers prioritize regulatory traceability, often accepting higher price points for documented supply chain durability. EU demand remains grounded in REACH compliance and eco-toxicity profile scrutiny. Japanese procurement focuses on electronic-grade standards with consistent lot-to-lot impurity profiles. Indian and Chinese buyers move quickly for technical grade lots, with supply sometimes strained by regulatory enforcement sweeps or raw material outages.
Based on multi-year procurement data and supplier-side input, modest upward price pressure remains likely into 2026. Key drivers: anticipated inflation in feedstock cost, ongoing tightening of effluent standards in Asia, and continued global logistics volatility. Growth in regulated application demand (pharma and agro intermediates) outweighs any near-term overcapacity in technical grades. Price forecast confidence remains highest for grades tied closely to well-documented raw material costs and regions with transparent regulatory reporting.
Analysis draws directly from internal procurement records, industry association reports tracking upstream aromatic intermediates (BPA, Phosgene, monochlorobenzene), and direct feedback from active contract buyers in each major economy. Triangulation with export statistics and price reporting agencies provides cross-verification against anecdotal spot-market intelligence. This excludes speculative projections and unverified broker-based pricing databases.
Environmental clampdowns in Eastern China caused several small and mid-size synthetic intermediates plants to temporarily idle, affecting both lead times and purchase pricing for all downstream users. Indian producers have observed increased cost pass-through from upstream chemical tariffs and fuel adjustments amid shifting Central government policy priorities. International buyers experienced intermittent vessel booking delays across Asia-Europe lanes, with no near-term change expected in ocean freight volatility.
Major revision cycles in EU REACH substance dossiers now require explicit impurity spectrum disclosure and batch traceability on all regulated-grade exports to Europe. US buyers face stricter due diligence on controlled substance reporting for intermediates entering pharmaceutical supply chains. Documented proof of non-use of prohibited substances in synthesis and full SDS/COC/COA disclosure remain baseline for audit pass-through. Manufacturers managing both technical and regulated-grade production lines have adjusted batch segregation and analytical recordkeeping to match country-specific compliance requirements.
Investments in in-line analytical detection and automated process control have replaced intermittent batch testing, especially for high-purity and pharma intermediates. Robust raw material sourcing partnerships minimize spot market exposure for key reagents. Our internal review teams conduct detailed qualification and requalification of subcontractors and tollers. In response to logistics uncertainties, we operate multi-lane shipping contracts and develop regionally buffered raw material inventories. Business continuity planning factors in anticipated regulatory shifts and cross-border transit risk assessments for all major customer regions.
1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone serves as an intermediate in pharmaceutical synthesis, an active building block in agrochemical development, and a reactive moiety in specialty dye manufacture. In pharmaceutical segments, it appears in multi-step syntheses where reactivity and impurity control influence final product performance. Agrochemical users look for tight mass balance to support regulatory submission, while colorant users prioritize shade consistency and solubility across batches. End-use determines grade requirements, and subtle differences in impurity profiles or moisture content directly impact yield or downstream process safety.
| Application Area | Preferred Grade(s) | Key Selection Factors |
|---|---|---|
| Pharmaceutical Intermediates | Pharma-grade | Low total/individual impurities, residual solvents profile, batch traceability |
| Agrochemicals | Technical-grade | Mass yield, allowed impurity levels as per local crop protection standards |
| Dyes and Pigments | Industrial-grade | Color consistency, solubility, trace metal content |
| Research/Analytical | High-purity or custom-grade | Purity, documentation, small scale suitability |
Start by identifying the downstream process—each field calls for specific property parameters. Pharmaceutical intermediate use requires stricter impurity control compared to pigment synthesis, where shade stability dominates.
Consult national and local guidelines—pharma and agro sectors mandate specific documentation, including permitted impurity thresholds and traceability. Discuss recordkeeping and audit trail demands with the manufacturer before finalizing grade.
Specify which impurity classes pose risks in your process. If a process involves further synthesis, even low-level byproducts can become problematic. For formulation applications, solubility and minor element contents may influence acceptance.
Higher grades incur increased material and analytical costs due to narrower processing windows and additional purification or documentation. For tonnage batches, some users balance cost versus risk by shortlisting grades matching only the most critical needs.
Laboratory validation against your actual process is the single most reliable selection method. Request batch-specific sample material, and run side-by-side comparisons against historic lots. Batch records, analytical chromatograms, and CoA review may identify hidden variability unknown at scale.
Consistency in pyrazolone ring precursor and halogenated aniline supply defines the baseline impurity profile of each batch. A known quality of chlorinated benzene ensures byproduct predictability. Selection of the synthetic route—whether batchwise or continuous—influences both throughput and trace impurity patterns.
Key control points in chlorination and condensation must balance conversion with selectivity. Uncontrolled reaction parameters lead to either over-chlorinated byproducts or incomplete conversion. Filtration methods and crystalline form selection directly affect moisture, fine content, and solubility properties. Technical and pharma grades diverge during purification, where additional chromatographic or recrystallization steps target de-bulking of minor process derivatives. Investment in repeated purification is non-trivial and justified based on final application.
Analytical checkpoints such as HPLC or GC profile review enable lot-by-lot consistency, with more detailed breakdowns available for pharma or custom lots. Typical values, including melting range and solubility, differ by application and grade. The final batch release aligns to internal standards set during product development and modified by customer or regulatory requests. Detailed certificate of analysis can be supplied for each lot, reflecting both standard and customer-specific criteria.
Our technical and production teams understand the demands placed on chemical intermediates for pharmaceuticals, agrochemicals, and pigments. Our manufacturing facility holds quality management system certifications congruent with recognized international standards across the plant, ensuring every batch of 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone receives lot-traceable oversight starting at raw material input.
Experienced operators follow established SOPs, supporting continual improvement audits and documented CAPA cycles. Batch logs link all inbound materials to their respective suppliers and include all test and analytical data for traceability. This approach minimizes batch-to-batch variation and forms the foundation for audit-readiness, important during regulatory, customer, or partner inspections.
Certifications and official statements for product origin, manufacturing route, and typical impurity profiles are available according to grade type and intended downstream use. Pharmaceutical and agrochemical grades may include GMP-oriented documentation subject to customer supply chain requirements and audit acceptance. For industrial grades, certificates of analysis (COAs) with detailed chromatographic data, as well as heavy metal and solvent residue statements, are provided upon request and follow each shipment.
Detailed product documentation includes full batch COA, specification sheet, and supporting analytical reports such as HPLC, GC, or NMR, as appropriate for the grade. Each grade’s documentation reflects its typical range of residual solvent, moisture, assay, and impurity limits, which our laboratory monitors as part of every batch release. Stability reports, if required, are prepared depending on the product’s storage and regulatory context. Customers can request additional application-specific quality disclosures during technical due diligence discussions.
Consistent output depends on reliable raw material sourcing, process route repeatability, and skilled workforce management. Production scheduling uses planned maintenance and demand forecasting to balance fixed-contract and spot sales, supporting customers facing variable order cycles. For customers requiring guaranteed lead times or volume, framework agreements and adjustable purchase plans align monthly or quarterly allocations with project needs.
Core production lines are dedicated to 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone to maintain batch traceability and rapid troubleshooting. In regions with fluctuating regulatory or supply environments, alternate raw material sources and validated backup routes can be deployed, as permitted by process safety and product uniformity criteria. Downstream contract customers benefit from allocated production slots and advance notification of plant maintenance or logistics disruptions.
Customers evaluating our product for formulation or synthesis scale-up may initiate a formal sample request with documented use case and target specifications. Samples are drawn from representative production batches, accompanied by full QA laboratory release documents. Bulk trial samples are available for pilot and commercial qualification trials to validate process compatibility and impurity carryover tolerances before final order commitment.
We recognize variability in end-user forecasting and inventory planning. Both fixed-volume contracts and rolling window purchase plans are supported by the commercial and logistics team, driven by real-time plant loading and raw material inbound schedules. Emergency dispatch or priority production orders can be arranged with lead time consultation. For R&D customers or those trialing new processes, smaller batch splits and customizable packaging formats are possible, contingent on the technical and warehouse workflow. Supply models can be discussed on a project basis with a dedicated technical liaison to ensure synchronization between manufacturing lead times and the customer’s consumption pattern.
Current research in 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone mostly focuses on increasing yield and purity during synthesis, driven by raw material cost fluctuations and tighter downstream impurity controls. R&D teams concentrate on optimizing condensation and cyclization conditions, since process parameters directly influence byproduct formation and isolation cost. Demand from pigment, pharmaceutical precursor, and analytical reagent sectors shapes the pace and scope of in-house research activities. For pharmaceutical intermediates, specific focus falls on trace metal and halogenated byproduct minimization, which requires frequent method adjustments based on customer and regional regulatory needs.
Analytical labs and dye manufacturers continue to expand the application range of this pyrazolone derivative, with notable demand sparked by its selectivity in metal complexation and color performance modulation. R&D also tracks new synthetic transformations where 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone serves as a building block for more complex functional molecules, especially for specialty dyes and molecular probes. Customer-initiated joint projects during technical audits often highlight unexplored applications, pushing the manufacturer’s process development to enable custom grade supply.
Large-scale production faces challenges related to controlling para- and ortho-chloro byproducts as raw chlorobenzene purity varies by supplier and region. Typical breakthrough efforts target continuous purification circuits or more efficient solid-liquid separations to improve batch consistency. Environmental controls are deployed to address halogenated waste management, particularly water wash streams. The implementation of targeted in-process analytics has started to shorten product release timelines and reduce off-spec rework rates. Some process innovations hinge on solvent recovery improvements to support cost and emission reduction objectives.
Based on internal forecasts, end-use demand is expected to grow with increasing specialty pigment and pharmaceutical intermediate consumption in both Asia and Europe. Shifts in regulatory requirements, especially those covering impurities in pharmaceutical sectors, will likely prompt diversified grade offerings and more customized downstream purification. Substantial volume increases tend to be tied to the introduction of new application patents or shifts in metal complexation protocols in analytical labs. Cross-industry collaboration with downstream partners is expected to drive more custom-tailored grades and tighter specification limits, which may influence both margin and capital expenditure decisions at the manufacturing level.
Manufacturing teams anticipate ongoing evolution towards greener process routes, including adoption of solvent-free or catalytic manufacturing steps and wider implementation of in-process analytical technologies. Process digitalization to support real-time batch release and deviation control already forms part of the mid-term investment roadmap. Advances in process intensification may enable higher throughputs with less waste generation. Supplier audits increasingly require full traceability and documented chain-of-custody for key reagents, shaping raw material procurement strategies. Technical differentiation will depend most on the ability to flexibly manufacture to both standard and customized impurity profiles without significant cost increase.
Green chemistry mandates impact the site’s waste treatment and solvent recycling designs. Projects currently underway focus on closed-loop solvent systems and minimization of auxiliary chemical use in both synthesis and purification. Most sustainability targets tie back to lifecycle analysis and the reduction in halogenated sludge and water discharge. Collaborations with local regulatory and academic partners aim to identify safer reagents and scalable waste valorization options. Product stewardship has adjusted to prioritize lower toxicity alternatives and support safer handling protocols at customer operations.
Direct support from process and formulation specialists addresses both routine troubleshooting and novel application development. Typical consultation covers analytics, problem sourcing in complex formulations, and batch-to-batch consistency management. Consultation depth varies depending on customer segment—analytical customers often require traceability and certificate documentation, while pigment producers value support with pigment performance modifications tied to raw pyrazolone lot variability.
Support teams provide formulation guidance grounded in results from bench trials and customer-specific conditions. For pigment end-use, technical staff advise on milling, dispersion, and compatibility with binders based on observed physical and chemical quality data. Pharmaceutical customers receive focused advice on purification routes and impurity rejection profiles. Manufacturing keeps robust communication with field technical teams to relay back any process feedback that would aid in refining product spec or process controls. Application support may also require on-site troubleshooting or supply of non-standard grades for process evaluation.
After product delivery, quality assurance tracks any reports on off-spec performance or unexpected impurity presence, coordinating corrective actions or possible root-cause investigations. Consistent internal documentation allows for rapid retrieval of production and quality data batches in question to support customer claims management. Long-term partnerships usually include collaborative audits and continuous specification improvement discussions. Training and product stewardship forms part of ongoing support, with updates provided on relevant process or regulatory changes as these impact end-use safety or performance criteria. Release criteria and batch consistency undergo regular reviews in response to evolving customer or regulatory demands.
Operations at our facility rely on advanced reaction controls and modern isolation processes tailored for 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone. Production batches run on dedicated lines, blocking cross-contamination and ensuring batch records align with customer requirements. From raw material intake to finished product, each step draws from hands-on manufacturing experience in handling heterocyclic intermediates and specialty fine chemicals.
Demand for 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone centers around dye intermediates, pigment synthesis, and pharmaceutical research. In pigment manufacture, this material functions as a building block for azo coupling and coloring compound development. Chemical research and synthesis programs utilize its structure for laboratory-scale modification and new product pipelines. As regulations and downstream applications evolve, our plant adapts campaign scheduling to support just-in-time supply for these sectors.
Process control holds top priority, with in-process checks at critical stages. Our quality lab monitors moisture content, residual solvents, and impurity profile on each lot. Technicians record melting point, appearance, and HPLC assay for every shipment. Real-world production experience taught us that product-to-product variability impacts both batch reproducibility and safety at our customers’ plants, so intervention triggers sit at multiple points in each campaign.
Material leaves our facility in sealed, industrial-grade containers with tamper-evident closures. Options include fiber drums and HDPE pails, protecting the material under demanding transit conditions. Batch coding tracks each delivery back to source. Manufacturing runs allow flexible lot sizes, accommodating R&D teams as well as commercial-scale processors. Warehousing practices prioritize quick turnover to maintain stock freshness and documented traceability.
Customers value direct access to our process engineers and chemists for application suggestions and troubleshooting. Feedback loops from client trials often reach our technical team, who adjust process parameters or product presentation based on data from mixing, scale-up, or formulation environments. With experience supporting pigment plants, formulation labs, and custom synthesis groups, we emphasize transparency on product performance and known interactions.
Our team bridges technical requirements and business objectives. By controlling every step of synthesis, packaging, and shipment, we cut uncertainty for industrial buyers and project managers. Bulk users and distributors secure stable, predictable deliveries, reducing the risk of production stoppages or compliance violations. Procurement teams rely on site-based quality assurance protocols, regular audit trails, and scalable production slots aligned with market cycles. Our plant’s reputation depends on reproducibility, technical credibility, and delivery reliability—qualities gained only from actual operational practice in specialty chemical production.
Manufacturing 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone requires constant attention to its core properties and stability traits. From our production lines to finished product handling, we always keep these realities in mind. As the entity responsible for every kilo that leaves our facility, we see the full lifecycle of this chemical, giving us first-hand insight into how it behaves in practical conditions, not just on the laboratory bench.
Structurally, our 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone features a pyrazolone backbone substituted with a 3-chlorophenyl group and a methyl group. This arrangement gives the molecule a unique balance of polarity and hydrophobicity. As produced on our line, the product forms a crystalline solid with a distinct off-white to pale yellow color. This makes visual inspection quite straightforward during quality checks. The melting point usually ranges within tight boundaries, so any deviation gets flagged by our QC team, helping to quickly identify impurities or production deviations.
Solubility matters a great deal. We observe moderate solubility in polar organic solvents and negligible solubility in water. This has real implications for both processing and storage: routine exposure to humidity or aqueous systems does not usually cause clumping or dissolution. Product separation and purification steps benefit from this solubility profile, supporting efficient isolation with minimal waste. The controlled volatility ensures low loss during drying, a continuous priority in our evaporation units.
We have run accelerated stability studies over multiple batches. Our technical staff monitors key indicators such as appearance, melting point, and assay over time. Direct sunlight, elevated heat, and moisture exposure stand out as stress factors. In normal warehouse conditions — ambient temperature, moderate humidity, indirect light — 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone proves robust, keeping both chemical integrity and purity over typical storage periods. Our records show that well-sealed containers, kept free from excess moisture, keep the product stable for at least 24 months with no significant change in its main characteristics.
From a chemical standpoint, the structure resists common degradation pathways such as hydrolysis and oxidation under ordinary conditions. In our process, we keep oxygen and water content in check, both during final crystallization and during packaging. As a result, our clients receive product with minimal risk of breakdown prior to use in their own manufacturing lines.
Every lot leaves our facility in packaging designed for stability: sealed, food-grade poly-lined fiber drums or robust polyethylene bags. These materials keep environmental stressors at bay. We also provide handling recommendations based on direct plant experience — avoid direct high heat, keep away from acids or strong oxidizers, and reseal containers quickly after sampling. Handling fluxes and friction pose no major safety concern under regular manufacturing settings. Static discharge does not impact the molecule’s stability or structure in our real-world operations.
Knowing exactly how a molecule performs outside of theoretical conditions is what makes a manufacturer’s insight different. The everyday experience handling 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone translates into upstream and downstream reliability for end users. We stay alert for new stability data, and are prepared to advise partners on best practice directly derived from our own practical results. Our technical documentation details exact analysis methods and real-world benchmarks — these are not just numbers on a sheet, but reflect real chemical journeys from start to finish inside our plant. For any advanced technical questions or data traceability needs, we can provide results and recommendations based on decades of continuous production and application feedback.
Producing 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone involves intensive chemical processing, multiple purification steps, and rigorous quality checks at each stage. Industry buyers often want to know about minimum order quantities and bulk pricing. As the direct manufacturer, we don’t just set MOQ policies based on arbitrary benchmarks; these stem from actual process requirements, material integrity, and economic realities tied to scale.
Our synthesis batches typically begin at the kilogram scale or higher, driven by equipment calibration and contamination controls in our own facility. Smaller orders create operational inefficiencies. Setup for each reaction—including reagent preparation, vessel cleaning, and downstream isolation—demands labor and materials, regardless of whether the batch is 500 grams or 50 kilograms. Below a certain order volume, the costs become disproportionate, both in wasted raw material and personnel hours. For this reason, most buyers will find our MOQ starts above that lab-scale gram range, reflecting the realities of commercial-scale output.
Volume discounts aren’t just a marketing strategy. They arise naturally from how chemical manufacturing works. Larger runs mean less waste and more efficient use of man-hours and raw materials. Our quality control (QC) team can concentrate efforts on larger samples, reducing per-unit overhead across each batch. When clients commit to multi-kilogram or multi-ton purchasing, costs for solvents, energy, and transport all fall per unit produced. This is why bulk pricing gets more aggressive with higher quantities—not because of arbitrary pricing, but grounded in measurable savings realized by our operation.
It’s also a matter of packaging, logistics, and risk management. Transporting ten separate kilogram packs involves more packaging, labeling, and freight documentation than one ten-kilogram drum. By consolidating shipments, we cut both monetary and environmental costs. Our facilities maintain strict inventory controls, so bulk orders help us maximize storage efficiency and cuts down on redundant handling.
We understand that every industrial user seeks value and reliability. Some research groups or start-ups only need trial quantities. In these cases, our technical team reviews requests and, depending on available material, sometimes accommodates low-volume supply for legitimate R&D purposes. That decision stems from direct communication with our production planning—not third-party speculation. For established customers or scale-ups, we often set progressive price breaks at defined quantity intervals, reflecting the stepwise drops in average manufacturing cost.
Our approach puts transparency and flexibility at the center of all commercial agreements. We detail our MOQ and bulk pricing structure upfront, including any cost-saving alternatives or batch-join options that might make lower volumes accessible. That depends on synchronization with our existing production calendar and inventory levels, not a one-size-fits-all answer.
Every inquiry about MOQ or bulk pricing starts a technical conversation—our sales engineers, production staff, and chemists all play a role in tailoring supply to real-world needs. Open dialogue lets us balance your project timelines with our batch schedules, which drives savings for both sides. By handling all negotiations and manufacturing in-house, we keep control over quality, cost, and delivery accuracy throughout the entire process.
Direct experience handling 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone from synthesis to global dispatch shows that precise shipping classifications and documentation keep international supply lines running and meet legal and safety responsibilities. This compound, recognized for its applications in dye intermediates and specialty chemistry, must navigate a tangle of international regulations before reaching downstream users.
Our regulatory specialist evaluates every new batch against UN Recommendations on the Transport of Dangerous Goods (often in lockstep with IMDG and IATA Dangerous Goods Regulations for sea and air). According to the Globally Harmonized System (GHS), 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone has drawn scrutiny for potential toxicity and chemical reactivity. Each outgoing shipment requires a Safety Data Sheet (SDS) containing all hazard data. We ensure the SDS details the correct UN number—if applicable—based on classification like corrosives (Class 8), toxic materials (Class 6.1), or not regulated if it falls outside these strict definitions. Most recent regulatory reviews have not listed this specific pyrazolone under the more hazardous shipping classes, though a full assessment of hazards, including toxicology and environmental behavior, stays our standard procedure.
Each shipment from our factories includes a full technical dossier—SDS (16-section format), Certificate of Analysis matching batch numbers, and any required export permits. These documents verify the integrity and safety profile of each drum. For most destinations, the commercial invoice gets paired with the packing list and, if regulated as a dangerous good, a dangerous goods declaration signed by our export manager.
Our standard packaging uses high-quality fiber drums fitted with polythene liners, designed to prevent contamination and withstand rough handling encountered in transit. We label each container with the product name, net weight, gross weight, batch number, and hazard pictogram if required by international transport conventions. Robust labeling ensures immediate recognition at ports and reduces border delays. Depending on the route, some governments request an additional shipper's declaration or import certificate. Our export department prepares these in-house.
Countries apply different controls regarding chemicals under their chemical control lists. Several demand prior registration or notification before clearing shipments. Our process ensures each batch export aligns with local and destination country regulations. Failure to comply can result in port detentions, fines, or shipment rejection. Our experienced compliance officers stay current on EU REACH, US TSCA, Chinese MEE, and Korean K-REACH updates.
Just-in-time deliveries are possible only by maintaining rigorous transport documentation and checking every detail against legal requirements. We maintain internal checklists and staff training to keep the procedures current. Advancing digital shipment tracking and pre-clearance systems have helped us reduce clearance times and anticipate documentation shortfalls before freight arrives at customs.
A direct manufacturer’s responsibility means shipments originate from verified facilities, documentation remains complete, and every container sent upholds safety and legal regulations from our dock to our client’s warehouse. We recognize the importance of strict adherence to both international law and our own quality standards in every shipment of 1-(3'-Chlorophenyl)-3-methyl-5-pyrazolone crossing borders.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
